Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PLAYSTUDIOS, Inc.MYPS · Entity 7100 | Director | July 16, 2026 | July 20, 2026 |
| SHIFT TECHNOLOGIES, INC.SFT · Entity 108083 | Director | December 01, 2022 | December 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PLAYSTUDIOS, Inc.
Report date July 16, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 364,992 |
Reported balance
After 2026-07-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 120,000 · Balance 364,992 F1: Represents grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F2: Represents shares of Class A Common Stock issuable upon vesting and settlement of Restricted Stock Units, which will vest in four (4) equal tranches on August 15, 2026, November 15, 2026, February 15, 2027 and May 15, 2027, subject to continued service as a member of the Board of Directors of the Issuer. F3: Includes shares of Class A Common Stock issuable upon vesting and settlement of Restricted Stock Units reported on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock.
F2: Represents shares of Class A Common Stock issuable upon vesting and settlement of Restricted Stock Units, which will vest in four (4) equal tranches on August 15, 2026, November 15, 2026, February 15, 2027 and May 15, 2027, subject to continued service as a member of the Board of Directors of the Issuer.
F3: Includes shares of Class A Common Stock issuable upon vesting and settlement of Restricted Stock Units reported on this Form 4.
SHIFT TECHNOLOGIES, INC.
Report date December 01, 2022 · Filed December 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 105,317 |
Reported balance
After 2022-12-01 transaction · row 1
1 source rowRow 1 · 2022-12-01 · Grant · Acquired 12,150 · Balance 105,317 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock, par value $0.0001 per share of Shift Technologies, Inc. (the "Company"). F2: The RSUs vest immediately upon issuance. Vested RSUs will be settled during the first open trading window of the Company following the date of vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock, par value $0.0001 per share of Shift Technologies, Inc. (the "Company").
F2: The RSUs vest immediately upon issuance. Vested RSUs will be settled during the first open trading window of the Company following the date of vesting.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Augmedix, Inc.
Report date October 02, 2024 · Filed October 04, 2024
Section 16 reporting ended · disclosed 2024-10-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-10-02 transaction · row 1
1 source rowRow 1 · 2024-10-02 · Disposition to issuer · Disposed 74,230 · Balance 0 F1: Disposed of in connection with the merger of Augmedix, Inc. ("Augmedix") with and into Anderson Merger Sub, Inc. (the "Merger Sub"), effective October 2, 2024 (the "Merger"), pursuant to the Agreement and Plan of Merger dated as of July 19, 2024, among Augmedix, Commure, Inc., and Merger Sub (the "Merger Agreement"). In connection with the Merger, the shares listed were canceled and converted into the right to receive $2.35 per share, without interest (the "Merger Consideration"), and subject to applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in connection with the merger of Augmedix, Inc. ("Augmedix") with and into Anderson Merger Sub, Inc. (the "Merger Sub"), effective October 2, 2024 (the "Merger"), pursuant to the Agreement and Plan of Merger dated as of July 19, 2024, among Augmedix, Commure, Inc., and Merger Sub (the "Merger Agreement"). In connection with the Merger, the shares listed were canceled and converted into the right to receive $2.35 per share, without interest (the "Merger Consideration"), and subject to applicable tax withholdings.
Matterport, Inc./DE
Report date February 28, 2025 · Filed March 03, 2025
Section 16 reporting ended · disclosed 2025-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 1
1 source rowRow 1 · 2025-02-28 · Disposition to issuer · Disposed 198,889 · Balance 0 F1: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-28 · Disposition to issuer · Disposed 39,325 · Balance 0 F2: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration").
F2: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2026 Filed Jul 20, 2026 22:42 UTC | PLAYSTUDIOS, Inc. MYPS · Entity 7100 | GrantClass A Common Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001826030-26-000002 · wk-form4_1784587373.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,992 F1 · kind: Represents grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F2 · shares: Represents shares of Class A Common Stock issuable upon vesting and settlement of Restricted Stock Units, which will vest in four (4) equal tranches on August 15, 2026, November 15, 2026, February 15, 2027 and May 15, 2027, subject to continued service as a member of the Board of Directors of the Issuer. F1 · acquired: Represents grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F3 · balance_after: Includes shares of Class A Common Stock issuable upon vesting and settlement of Restricted Stock Units reported on this Form 4. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 20:57 UTC | PLAYSTUDIOS, Inc. MYPS · Entity 7100 | GrantClass A Common Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-036457 · wk-form4_1753822667.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,992 F1 · kind: Grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F2 · shares: Represents shares of Class A Common Stock to be issued upon vesting and settlement of Restricted Stock Units, which will vest in four (4) equal tranches on August 15, 2025, November 15, 2025, February 15, 2026 and May 15, 2026, subject to continued service as a member of the Board of Directors of the Issuer. F1 · acquired: Grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F3 · balance_after: Includes shares of Class A Common Stock to be issued upon vesting and settlement of Restricted Stock Units reported on this Form 4. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:04 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Disposition to issuerRestricted Stock Units · Derivative | 39,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-019781 · tm258067-2_4seq1.xml · derivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 39,325 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). F2 · kind: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). F2 · derivative.exercise_date: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). F2 · derivative.expiration_date: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:04 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Disposition to issuerClass A Common Stock | 198,889 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-019781 · tm258067-2_4seq1.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration"). F1 · price: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration"). Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 13:01 UTC | Augmedix, Inc. AUGX · Entity 86996 | Disposition to issuerCommon Stock | 74,230 | $2.35 | $174,440.50 |
DisclosureSEC source: 0001213900-24-085349 · ownership.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · acquired: Disposed of in connection with the merger of Augmedix, Inc. ("Augmedix") with and into Anderson Merger Sub, Inc. (the "Merger Sub"), effective October 2, 2024 (the "Merger"), pursuant to the Agreement and Plan of Merger dated as of July 19, 2024, among Augmedix, Commure, Inc., and Merger Sub (the "Merger Agreement"). In connection with the Merger, the shares listed were canceled and converted into the right to receive $2.35 per share, without interest (the "Merger Consideration"), and subject to applicable tax withholdings. Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 23:48 UTC | PLAYSTUDIOS, Inc. MYPS · Entity 7100 | GrantClass A Common Stock | 67,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037454 · wk-form4_1723765704.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,992 F1 · kind: Grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F2 · shares: Represents shares of Class A Common Stock to be issued upon vesting and settlement of Restricted Stock Units, which will vest in four (4) equal tranches on August 15, 2024, November 15, 2024, February 15, 2025 and May 15, 2025, subject to continued service as a member of the Board of Directors of the Issuer. F1 · acquired: Grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F3 · balance_after: Includes shares of Class A Common Stock to be issued upon vesting and settlement of Restricted Stock Units reported on this Form 4. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 21:59 UTC | Augmedix, Inc. AUGX · Entity 86996 | Exercise / conversionRestricted Stock Units · Derivative | 21,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-061518 · ownership.xml · derivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,598 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On July 13, 2023 (the "Grant Date"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date. F2 · derivative.expiration_date: On July 13, 2023 (the "Grant Date"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 21:59 UTC | Augmedix, Inc. AUGX · Entity 86996 | Exercise / conversionCommon Stock | 21,598 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-061518 · ownership.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 18:58 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Unit · Derivative | 39,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005012 · primarydocument.xml · derivative · entry 3 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,325 Underlying: Class A Common Stock · 39,325 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F3 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) June 10, 2025 and (ii) the date of the Company's 2025 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) June 10, 2025 and (ii) the date of the Company's 2025 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 18:58 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionRestricted Stock Unit · Derivative | 60,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005012 · primarydocument.xml · derivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 60,763 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on June 10, 2024, which is the date of the Company's 2024 annual meeting of shareholders. F2 · derivative.expiration_date: The RSUs vested in full on June 10, 2024, which is the date of the Company's 2024 annual meeting of shareholders. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 18:58 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionClass A Common Stock | 60,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005012 · primarydocument.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2023 Filed Aug 22, 2023 16:34 UTC | Matterport, Inc./DE MTTR · Entity 82549 | PurchaseClass A Common Stock | 100,000 | $2.46 | $245,940.00 |
DisclosureSEC source: 0001562180-23-006510 · primarydocument.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,126 Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:34 UTC | Augmedix, Inc. AUGX · Entity 86996 | GrantRestricted Stock Units · Derivative | 21,598 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001213900-23-057474 · ownership.xml · derivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,598 Underlying: Common Stock · 21,598 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Unit ("RSU") is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSU will vest in full on the one-year anniversary of July 13, 2023, so long as the Reporting Person remains a director on such date. F2 · derivative.expiration_date: The RSU will vest in full on the one-year anniversary of July 13, 2023, so long as the Reporting Person remains a director on such date. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 18:33 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Unit · Derivative | 60,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005564 · primarydocument.xml · derivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,763 Underlying: Class A Common Stock · 60,763 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F2 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) June 27, 2024 and (ii) the date of the Company's 2024 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) June 27, 2024 and (ii) the date of the Company's 2024 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 23:46 UTC | PLAYSTUDIOS, Inc. MYPS · Entity 7100 | GrantClass A Common Stock | 31,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001826030-23-000003 · wk-form4_1687477587.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,424 F1 · kind: Grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F2 · shares: Represents shares of Class A Common Stock to be issued upon vesting and settlement of Restricted Stock Units, which will vest in four (4) equal tranches on August 15, 2023, November 15, 2023, February 15, 2024 and May 15, 2024, subject to continued service as a member of the Board of Directors of the Issuer. F1 · acquired: Grant of Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. F3 · balance_after: Includes shares of Class A Common Stock to be issued upon vesting and settlement of Restricted Stock Units reported on this Form 4. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 17:48 UTC | Augmedix, Inc. AUGX · Entity 86996 | Exercise / conversionRestricted Stock Units · Derivative | 52,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-049751 · ownership.xml · derivative · entry 2 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date. F2 · derivative.expiration_date: On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 17:48 UTC | Augmedix, Inc. AUGX · Entity 86996 | Exercise / conversionCommon Stock | 52,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-049751 · ownership.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 12:53 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionRestricted Stock Units · Derivative | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005193 · primarydocument.xml · derivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 38,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on June 13, 2023, which is the date of the Company's 2023 annual meeting of shareholders. F2 · derivative.expiration_date: The RSUs vested in full on June 13, 2023, which is the date of the Company's 2023 annual meeting of shareholders. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 12:53 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionClass A Common Stock | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005193 · primarydocument.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:09 UTC | SHIFT TECHNOLOGIES, INC. SFT · Entity 108083 | GrantClass A Common Stock | 12,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001762322-22-000127 · wf-form4_167001533332360.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,317 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock, par value $0.0001 per share of Shift Technologies, Inc. (the "Company"). F2 · shares: The RSUs vest immediately upon issuance. Vested RSUs will be settled during the first open trading window of the Company following the date of vesting. Read SEC document |
| September 15, 2022 Filed Sep 15, 2022 17:30 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 213,823 | $4.18 | $893,609.08 |
DisclosureSEC source: 0000899243-22-031170 · doc4.xml · nonDerivative · entry 3 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,650,164 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.07 to $4.26. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 17:30 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 368,255 | $4.22 | $1,555,766.90 |
DisclosureSEC source: 0000899243-22-031170 · doc4.xml · nonDerivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,863,987 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.31. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 17:30 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 330,670 | $4.53 | $1,497,075.36 |
DisclosureSEC source: 0000899243-22-031170 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,232,242 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.59. The reporting person undertakes to provide Matterport, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2022 Filed Sep 13, 2022 21:06 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 867,094 | $4.66 | $4,042,132.10 |
DisclosureSEC source: 0000899243-22-030977 · doc4.xml · nonDerivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,562,912 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.75. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 21:06 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 426,304 | $4.61 | $1,965,730.37 |
DisclosureSEC source: 0000899243-22-030977 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 19,430,006 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.67. The reporting person undertakes to provide Matterport, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| July 13, 2022 Filed Jul 20, 2022 12:03 UTC | SHIFT TECHNOLOGIES, INC. SFT · Entity 108083 | GrantClass A Common Stock | 93,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001762322-22-000067 · wf-form4_165833301145833.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,167 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock, par value $0.0001 per share of Shift Technologies, Inc. (the "Company"). F2 · shares: The RSUs vest on July 13, 2023, subject to continued service with the Company or an affiliate of the Company. Vested RSUs will be settled during the first open trading window of the Company following the date of vesting. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:59 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Units · Derivative | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-025872 · doc4.xml · derivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,126 Underlying: Class A Common Stock · 38,126 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Matterport, Inc. (the "Company") Class A common stock. F2 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) July 6, 2023 and (ii) the date of the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) July 6, 2023 and (ii) the date of the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:04 UTC | Augmedix, Inc. AUGX · Entity 86996 | GrantRestricted Stock Units · Derivative | 52,632 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001213900-22-034073 · ownership.xml · derivative · entry 1 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,632 Underlying: Common Stock · 52,632 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Unit ("RSU") is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.expiration_date: The RSU will vest in full on the one-year anniversary of June 16, 2022, so long as the Reporting Person remains a director on such date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:57 UTC | PLAYSTUDIOS, Inc. MYPS · Entity 7100 | GrantClass A Common Stock | 25,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-016908 · wf-form4_165490183495045.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,510 F1 · kind: Grant of restricted stock units. F2 · shares: Represents shares that will be issued upon the vesting of a grant of restricted stock units, which vests in 12 equal monthly increments commencing one month after the grant date, subject to continued service as a member of the board of directors of the Company. F1 · acquired: Grant of restricted stock units. F2 · balance_after: Represents shares that will be issued upon the vesting of a grant of restricted stock units, which vests in 12 equal monthly increments commencing one month after the grant date, subject to continued service as a member of the board of directors of the Company. Read SEC document |
| May 25, 2022 Filed May 26, 2022 18:03 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 327,270 | $5.10 | $1,669,960.63 |
DisclosureSEC source: 0000899243-22-019802 · doc4.xml · nonDerivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 19,856,310 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.19. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| May 24, 2022 Filed May 26, 2022 18:03 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 249,969 | $5.08 | $1,269,117.61 |
DisclosureSEC source: 0000899243-22-019802 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 20,183,580 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.29. The reporting person undertakes to provide Matterport, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| May 23, 2022 Filed May 24, 2022 16:38 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 760,500 | $5.37 | $4,080,386.70 |
DisclosureSEC source: 0000899243-22-019370 · doc4.xml · nonDerivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 20,433,549 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.47. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| May 20, 2022 Filed May 24, 2022 16:38 UTC | Matterport, Inc./DE MTTR · Entity 82549 | SaleClass A Common Stock | 868,407 | $5.43 | $4,715,276.33 |
DisclosureSEC source: 0000899243-22-019370 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 21,194,049 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.69. The reporting person undertakes to provide Matterport, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P., except to the extent of his pecuniary interest therein. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 18:15 UTC | Matterport, Inc./DE MTTR · Entity 82549 | ConversionEarn-Out Shares · Derivative | 2,204,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-004888 · doc4.xml · derivative · entry 3 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 2,204,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On July 22, 2021, Matterport, Inc. (formerly known as Gores Holdings VI, Inc.) (the "Issuer") consummated the merger contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 7, 2021, by and among the Issuer, Maker Merger Sub, Inc., Maker Merger Sub II, LLC and Matterport Operating, LLC ("Legacy Matterport"). F3 · derivative.exercise_price: Pursuant to the terms of the Merger Agreement, former holders of Legacy Matterport common stock and former holders of Legacy Matterport options and restricted stock units are entitled to receive their pro rata share of up to 23,460,000 shares of the Issuer's Class A Common Stock (the "Earn-Out Shares") during the five-year period following the Lockup Expiration Date (as defined in the Merger Agreement) if the daily volume-weighted average price of the Issuer's Class A Common Stock has been greater than the thresholds set forth in the Merger Agreement for a period of at least 10 trading days out of a 30 consecutive trading day period. The issuance of such shares is subject to certain adjustments set forth in the Merger Agreement. F4 · shares: Consists of 2,204,400 Earn-Out Shares entitled to be received by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P. except to the extent of his pecuniary interest therein. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, former holders of Legacy Matterport common stock and former holders of Legacy Matterport options and restricted stock units are entitled to receive their pro rata share of up to 23,460,000 shares of the Issuer's Class A Common Stock (the "Earn-Out Shares") during the five-year period following the Lockup Expiration Date (as defined in the Merger Agreement) if the daily volume-weighted average price of the Issuer's Class A Common Stock has been greater than the thresholds set forth in the Merger Agreement for a period of at least 10 trading days out of a 30 consecutive trading day period. The issuance of such shares is subject to certain adjustments set forth in the Merger Agreement. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, former holders of Legacy Matterport common stock and former holders of Legacy Matterport options and restricted stock units are entitled to receive their pro rata share of up to 23,460,000 shares of the Issuer's Class A Common Stock (the "Earn-Out Shares") during the five-year period following the Lockup Expiration Date (as defined in the Merger Agreement) if the daily volume-weighted average price of the Issuer's Class A Common Stock has been greater than the thresholds set forth in the Merger Agreement for a period of at least 10 trading days out of a 30 consecutive trading day period. The issuance of such shares is subject to certain adjustments set forth in the Merger Agreement. F4 · ownership.nature: Consists of 2,204,400 Earn-Out Shares entitled to be received by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P. except to the extent of his pecuniary interest therein. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 18:15 UTC | Matterport, Inc./DE MTTR · Entity 82549 | ConversionClass A Common Stock | 2,204,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-004888 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 22,062,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Consists of 22,062,456 shares held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P. except to the extent of his pecuniary interest therein. The reporting person last disclosed common stock holdings in a Form 4 filed on July 26, 2021 (the "Original Form 4"). At that time, due to a scrivener's error, his holdings attributable to shares held by DCM VI, L.P. were overstated by nine shares. The Original Form 4 also inadvertently omitted the acquisition of shares by the 2012 Krikorian Revocable Trust being reported herein. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:28 UTC | Augmedix, Inc. AUGX · Entity 86996 | PurchaseCommon Stock | 437,500 | $4.00 | $1,750,000.00 |
DisclosureSEC source: 0001213900-21-055919 · ownership.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,168,918 F1 · ownership.direct: These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. F1 · ownership.nature: These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 21:54 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantClass A Common Stock | 19,858,065 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-030093 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 19,858,065 F1 · price: Pursuant to the Merger Agreement, dated February 7, 2021 (the "Merger Agreement"), by and among Gores Holdings VI, Inc. (the "Issuer"), Maker Merger Sub, Inc., Maker Merger Sub II, LLC and Matterport, Inc. (the "Company"), each share of the Company's common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement was automatically converted into the right to receive a number of shares of the Issuer's Class A Common Stock based on the Per Share Company Common Stock Consideration (as defined in the Merger Agreement). F2 · ownership.nature: Consists of shares of Class A Common Stock held by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P. except to the extent of his pecuniary interest therein. Read SEC document |
| July 22, 2021 Filed Feb 4, 2022 18:15 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantEarn-Out Shares · Derivative | 2,204,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-004888 · doc4.xml · derivative · entry 2 Krikorian Jason · CIK 0001826030 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,204,400 Underlying: Class A Common Stock · 2,204,400 shares Expires not disclosed F2 · derivative.exercise_price: On July 22, 2021, Matterport, Inc. (formerly known as Gores Holdings VI, Inc.) (the "Issuer") consummated the merger contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 7, 2021, by and among the Issuer, Maker Merger Sub, Inc., Maker Merger Sub II, LLC and Matterport Operating, LLC ("Legacy Matterport"). F3 · derivative.exercise_price: Pursuant to the terms of the Merger Agreement, former holders of Legacy Matterport common stock and former holders of Legacy Matterport options and restricted stock units are entitled to receive their pro rata share of up to 23,460,000 shares of the Issuer's Class A Common Stock (the "Earn-Out Shares") during the five-year period following the Lockup Expiration Date (as defined in the Merger Agreement) if the daily volume-weighted average price of the Issuer's Class A Common Stock has been greater than the thresholds set forth in the Merger Agreement for a period of at least 10 trading days out of a 30 consecutive trading day period. The issuance of such shares is subject to certain adjustments set forth in the Merger Agreement. F4 · shares: Consists of 2,204,400 Earn-Out Shares entitled to be received by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P. except to the extent of his pecuniary interest therein. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, former holders of Legacy Matterport common stock and former holders of Legacy Matterport options and restricted stock units are entitled to receive their pro rata share of up to 23,460,000 shares of the Issuer's Class A Common Stock (the "Earn-Out Shares") during the five-year period following the Lockup Expiration Date (as defined in the Merger Agreement) if the daily volume-weighted average price of the Issuer's Class A Common Stock has been greater than the thresholds set forth in the Merger Agreement for a period of at least 10 trading days out of a 30 consecutive trading day period. The issuance of such shares is subject to certain adjustments set forth in the Merger Agreement. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, former holders of Legacy Matterport common stock and former holders of Legacy Matterport options and restricted stock units are entitled to receive their pro rata share of up to 23,460,000 shares of the Issuer's Class A Common Stock (the "Earn-Out Shares") during the five-year period following the Lockup Expiration Date (as defined in the Merger Agreement) if the daily volume-weighted average price of the Issuer's Class A Common Stock has been greater than the thresholds set forth in the Merger Agreement for a period of at least 10 trading days out of a 30 consecutive trading day period. The issuance of such shares is subject to certain adjustments set forth in the Merger Agreement. F4 · ownership.nature: Consists of 2,204,400 Earn-Out Shares entitled to be received by DCM VI, L.P. Jason Krikorian is a general partner at DCM, which is an affiliate of DCM VI, L.P. Mr. Krikorian disclaims beneficial ownership of all shares held by DCM VI, L.P. except to the extent of his pecuniary interest therein. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 18:40 UTC | Augmedix, Inc. NONE · Entity 86996 | GrantWarrant (right to buy) · Derivative | 269,490 | Not disclosed Strike: $2.88 | Not disclosed |
DisclosureSEC source: 0001209191-20-054213 · doc4.xml · derivative · entry 4 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 269,490 Underlying: Common Stock · 269,490 shares Expires 2029-09-02 F1 · price: On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer. F4 · derivative.exercise_date: The warrants are fully vested and exerciseable. F2 · ownership.nature: These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 18:40 UTC | Augmedix, Inc. NONE · Entity 86996 | GrantCommon Stock | 20,007 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-054213 · doc4.xml · nonDerivative · entry 3 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 20,007 F1 · price: On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer. F3 · ownership.nature: These securities are held of record by A-Fund, L.P. ("A-Fund"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of A-Fund. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 18:40 UTC | Augmedix, Inc. NONE · Entity 86996 | PurchaseCommon Stock | 666,667 | $3.00 | $2,000,001.00 |
DisclosureSEC source: 0001209191-20-054213 · doc4.xml · nonDerivative · entry 2 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,731,418 F2 · ownership.nature: These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 18:40 UTC | Augmedix, Inc. NONE · Entity 86996 | GrantCommon Stock | 3,064,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-054213 · doc4.xml · nonDerivative · entry 1 Krikorian Jason · CIK 0001826030 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,064,751 F1 · price: On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer. F2 · ownership.nature: These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.